Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00032877 · ClinicalTrials.gov registry record

Genetic Analysis of Fraser Syndrome and Fryns Syndrome

A clinical trial of Fraser Syndrome and Fryns Syndrome, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
400
Enrollment target
1
Study location

NCT00032877: Completed study of Fraser Syndrome and Fryns Syndrome, sponsored by National Human Genome Research Institute (NHGRI).

NCT00032877 is a study of Fraser Syndrome and Fryns Syndrome that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00032877, a study of Fraser Syndrome and Fryns Syndrome, has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

This study will examine blood or other tissue samples from patients with Fraser syndrome and patients with Fryns syndrome to try to identify the gene responsible for these diseases. Fraser syndrome is characterized by congenital abnormalities including cryptophthalmos (lack of eyelid formation), syndactyly (webbed fingers or toes) and abnormal genitalia. Patients may also have abnormalities of the nose, ears and larynx (voice box), cleft lip or palate, and kidney agenesis. Fryns syndrome is characterized by hernia through the diaphragm, cloudy cornea, coarse facial features, cleft lip or palate, abnormal fingers and toes, heart, kidney and brain malformations and hydrocephalus (accumulation of fluid around the brain). This protocol consists of laboratory study only; it does not involve patient care or patient counseling. Patients with Fraser syndrome or Fryns syndrome are eligible for this study. Parents and healthy siblings of patients will also be included for genetic study, and parents of children with undiagnosed multiple congenital anomalies syndromes will be included for comparison study. Participants will provide a blood sample (about 8 to 10 teaspoons from adults; 1 to 3 teaspoons from children) or sample of skin cells collected by swabbing the inner surface of the cheek. Some patients may undergo a skin biopsy, in which a small skin sample (about 1/8-inch in diameter) is surgically removed. The tissue samples will be used to obtain DNA (genetic material) for laboratory testing. A permanent cell line-a collection of cells grown in the laboratory from the original tissue specimen-will also be established to enable additional testing in the future.

Study Locations (1)

Maryland

  • National Human Genome Research Institute (NHGRI) - Bethesda

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2002-04
Est. Completion 2003-02

What the finished NCT00032877 record still lists

NCT00032877 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 4 conditions, with Fraser Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT00032877 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00032877 about?

NCT00032877 is a clinical study titled "Genetic Analysis of Fraser Syndrome and Fryns Syndrome". This study will examine blood or other tissue samples from patients with Fraser syndrome and patients with Fryns syndrome to try to identify the gene responsible for these diseases. Fraser syndrome is characterized by congenital abnormalities including cryptophthalmos (lack of eyelid formation), syn...

What is the current status of trial NCT00032877?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2002-04. Estimated completion is 2003-02.

What conditions does trial NCT00032877 study?

This clinical trial studies the following conditions: Fraser Syndrome, Fryns Syndrome, Chromosomal Abnormalities, Abnormalities, Multiple.

Who is sponsoring clinical trial NCT00032877?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00032877 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00032877, the US trial registry maintained by the National Library of Medicine. NCT00032877 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.